IDEAYA Biosciences Inc President and CEO Yujiro Hata Sells 75,000 Shares [Yahoo! Finance]
IDEAYA Biosciences, Inc. (IDYA)
Last ideaya biosciences, inc. earnings: 3/24 06:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
The insider executed the sale at an average price of $40.15 per share, resulting in a total transaction amount of $3,011,250. IDEAYA Biosciences Inc is a precision medicine company focused on the discovery and development of targeted therapeutics for patients with cancer. The company is dedicated to improving the treatment of cancer through personalized medicine, leveraging its expertise in molecular diagnostics and bioinformatics to identify and develop targeted therapies. Warning! GuruFocus has detected 5 Warning Signs with IDYA. Over the past year, the insider has sold a total of 150,000 shares of IDEAYA Biosciences Inc and has not made any purchases of the stock. The recent transaction on January 16 is part of this selling trend. The insider transaction history for IDEAYA Biosciences Inc shows a pattern of insider sales, with 17 insider sells and no insider buys over the past year. On the day of the insider's recent sale, shares of IDEAYA Biosciences Inc were trading at
Show less
Read more
Impact Snapshot
Event Time:
IDYA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IDYA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IDYA alerts
High impacting IDEAYA Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
IDYA
News
- IDEAYA Biosciences Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)PR Newswire
- IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored Study [Yahoo! Finance]Yahoo! Finance
- IDEAYA Biosciences Announces ASCO 2024 Oral Presentation for Darovasertib in Neoadjuvant Uveal Melanoma Phase 2 Investigator Sponsored StudyPR Newswire
- IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung Cancer [Yahoo! Finance]Yahoo! Finance
- IDEAYA Biosciences Announces Selection of Move-Forward Phase 2 Expansion Dose for IDE397 Monotherapy in MTAP-Deletion Squamous Non-Small Cell Lung CancerPR Newswire
IDYA
Earnings
- 5/9/23 - Beat
IDYA
Sec Filings
- 4/24/24 - Form ARS
- 4/19/24 - Form DEF
- 3/12/24 - Form 8-K
- IDYA's page on the SEC website